Lorcaserin Extended-Release Tablets and Ratio-Ipratropium Udv
Determining the interaction of Lorcaserin Extended-Release Tablets and Ratio-Ipratropium Udv and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: ipratropium
Brand name: Atrovent HFA, Atrovent
Synonyms: Ipratropium inhalation, Ipratropium (Oral Inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Ratio-Ketorolac
- Lorcaserin Extended-Release Tablets-Ratio-Levobunolol
- Lorcaserin Extended-Release Tablets-Ravicti
- Lorcaserin Extended-Release Tablets-Ravicti Oral Liquid
- Lorcaserin Extended-Release Tablets-Rayaldee
- Lorcaserin Extended-Release Tablets-Rayos
- Ratio-Ipratropium Udv-Lorcaserin Hydrochloride
- Ratio-Ipratropium Udv-Lorcaserin Tablets
- Ratio-Ipratropium Udv-Lorcet
- Ratio-Ipratropium Udv-Lorcet Plus
- Ratio-Ipratropium Udv-Lorcet Tablets
- Ratio-Ipratropium Udv-Lorlatinib